Showing results (211-220 of 443) with videos related to

Sort By:
Pageof 45
Clinical Parkinsonism & Related Disorders|March 7, 2022
The impact of recurrent Covid-19 waves on patients with Functional Movement Disorders: A follow-up studyAngela Sandri, Ilaria A Di Vico, Marianna Riello, et al.
Clinical Parkinsonism & Related Disorders|March 29, 2022
Recognizing myorhythmia 4 months after stroke - A teaching videoSebastian Finkener, Tobias Piroth, Magdalena Högg, et al.
Clinical Parkinsonism & Related Disorders|January 3, 2023
Long-term results of carbidopa/levodopa enteral suspension across the day in advanced Parkinson's disease: Post-hoc analyses from a large 54-week trialRajesh Pahwa, Jason Aldred, Aristide Merola, et al.
Clinical Parkinsonism & Related Disorders|January 3, 2023
Pallidal stimulation-induced psychosis and suicidality in Parkinson's diseaseSebastian Hanna, Vala Palmadottir, Paul L Penar, et al.
Clinical Parkinsonism & Related Disorders|May 6, 2020
Prediction of cognitive progression in Parkinson's disease using three cognitive screening measuresHojoong M Kim, Carter Nazor, Cyrus P Zabetian, et al.
Clinical Parkinsonism & Related Disorders|August 29, 2022
Patient selection and injection techniques for botulinum neurotoxin in oromandibular dystoniaRoongroj Bhidayasiri, Suppata Maytharakcheep, Daniel D Truong
Clinical Parkinsonism & Related Disorders|September 9, 2022
Salivary ATP13A2 is a potential marker of therapy-induced motor complications and is expressed by inclusions in submandibulary glands in Parkinson ´s diseaseEmilio Fernández-Espejo, Ana L Gavito, Juan Suárez, et al.
Clinical Parkinsonism & Related Disorders|November 12, 2021
Dopamine genetic risk score predicts impulse control behaviors in Parkinson's diseaseAlison Hall, Samuel R Weaver, Lindsey J Compton, et al.
Clinical Parkinsonism & Related Disorders|October 17, 2022
Extension of community healthcare outcomes in Parkinson disease (Parkinson ECHO): A feasibility studyLee E Neilson, Jennifer Wilhelm, Margaret McLain McDonnell, et al.
Clinical Parkinsonism & Related Disorders|February 3, 2025
A four-year trajectory of Alexithymia in Parkinson's disease patientsLea Krey, Annika Heike Ritzrau, Theresa Schnur, et al.
Pageof 45